Guardant Health’s blood screening test for colorectal cancer receives federal approval. The FDA warns about dosing errors tied to compounded versions of GLP-1 drugs. And a new study shows that a blood test can accurately diagnose Alzheimer’s disease. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
